Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 3
1978 4
1979 1
1980 2
1981 4
1982 2
1983 5
1987 1
1989 3
1990 2
1991 3
1992 1
1993 3
1994 7
1995 6
1996 15
1997 7
1998 4
1999 3
2000 3
2001 3
2002 5
2003 9
2004 8
2005 9
2006 9
2007 8
2008 10
2009 13
2010 18
2011 18
2012 13
2013 22
2014 8
2015 11
2016 15
2017 14
2018 13
2019 11
2020 20
2021 15
2022 11
2023 17
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
Introduction.
Collin-Vézina D, Garrido E. Collin-Vézina D, et al. Among authors: garrido e. Child Abuse Negl. 2017 Apr;66:1. doi: 10.1016/j.chiabu.2017.03.022. Child Abuse Negl. 2017. PMID: 28413053 No abstract available.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E, Pera G, Grgurevic I, Caballeria L, Piano S, van Kleef L, Reichert M, Roulot D, Pericàs JM, Schattenberg JM, Tsochatztis EA, Guha IN, Garcia-Retortillo M, Hernández R, Hoyo J, Fuentes M, Expósito C, Martínez A, Such P, Madir A, Detlefsen S, Tonon M, Martini A, Ma AT, Pich J, Bonfill E, Juan M, Soria A, Carol M, Gratacós-Ginès J, Morillas RM, Toran P, Navarrete JM, Torrejón A, Fournier C, Llorca A, Arslanow A, de Koning HJ, Cucchietti F, Manns M, Newsome PN, Hernáez R, Allen A, Angeli P, de Knegt RJ, Karlsen TH, Galle P, Wong VW, Fabrellas N, Castera L, Krag A, Lammert F, Kamath PS, Ginès P; LiverScreen Consortium Investigators. Serra-Burriel M, et al. Lancet. 2023 Sep 16;402(10406):988-996. doi: 10.1016/S0140-6736(23)01174-1. Epub 2023 Aug 9. Lancet. 2023. PMID: 37572680
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094. Eur Heart J. 2021. PMID: 33792669 Free PMC article. Clinical Trial.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink HJL, Cherney D, Postmus D, Stefánsson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22. Kidney Int. 2022. PMID: 34560136 Free article. Clinical Trial.
Acute, subacute and chronic mountain sickness.
Garrido E, Botella de Maglia J, Castillo O. Garrido E, et al. Rev Clin Esp (Barc). 2021 Oct;221(8):481-490. doi: 10.1016/j.rceng.2019.12.009. Epub 2020 Nov 2. Rev Clin Esp (Barc). 2021. PMID: 34583826 Review.
Une recette épicée contre les bactéries.
Garrido E, Lopez P, Mendes Ferreira VD, Prutyanova Y, Siebenmann E, Zholdokov M, Guilhen C, Soulié P. Garrido E, et al. Rev Med Suisse. 2022 Jan 19;18(764-5):88-89. doi: 10.53738/REVMED.2022.18.764-65.88. Rev Med Suisse. 2022. PMID: 35048587 French. No abstract available.
Acute, subacute and chronic mountain sickness.
Garrido E, Botella de Maglia J, Castillo O. Garrido E, et al. Rev Clin Esp. 2020 Mar 17:S0014-2565(20)30064-3. doi: 10.1016/j.rce.2019.12.013. Online ahead of print. Rev Clin Esp. 2020. PMID: 32197780 Review. English, Spanish.
Percutaneous liver biopsy.
Lopez-Sanroman A, Garcia-Gonzalez M, Garcia-Hoz F, Garrido E. Lopez-Sanroman A, et al. Among authors: garrido e. Clin Gastroenterol Hepatol. 2011 Mar;9(3):278; author reply 278-9. doi: 10.1016/j.cgh.2010.10.032. Epub 2010 Nov 9. Clin Gastroenterol Hepatol. 2011. PMID: 21070879 No abstract available.
345 results